| scholarly article | Q13442814 |
| P50 | author | Jamie van Langelaar | Q88370936 |
| Malou Janssen | Q116784956 | ||
| P2093 | author name string | Rogier Q Hintzen | |
| Helga E de Vries | |||
| S Marieke van Ham | |||
| Marvin M van Luijn | |||
| Annet F Wierenga-Wolf | |||
| Peter-Paul A Unger | |||
| Marie-José Melief | |||
| Liza Rijvers | |||
| Theodora A Siepman | |||
| P2860 | cites work | Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 |
| JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Q47439880 | ||
| Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. | Q47935420 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Prospective study on the relationship between infections and multiple sclerosis exacerbations | Q48626875 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. | Q51039778 | ||
| Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. | Q52940412 | ||
| Toll-like receptor stimulation as a third signal required for activation of human naive B cells. | Q53632191 | ||
| IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE. | Q54223580 | ||
| T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention | Q56582190 | ||
| Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? | Q57041523 | ||
| Memory B Cells Activate Brain-Homing, Autoreactive CD4 T Cells in Multiple Sclerosis | Q58709181 | ||
| Antigen-specific interaction between T and B cells | Q59063745 | ||
| Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis | Q59352704 | ||
| Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system | Q61709654 | ||
| Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing−remitting multiple sclerosis patients | Q62612955 | ||
| Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis | Q64066412 | ||
| TLR9 signaling in B cells determines class switch recombination to IgG2a | Q79718037 | ||
| Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients | Q87673522 | ||
| EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 | Q24657388 | ||
| Regulation of germinal center B-cell differentiation | Q26766726 | ||
| B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation | Q26770852 | ||
| Salmonella as a model for non-cognate Th1 cell stimulation | Q28082931 | ||
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| T-bet regulates IgG class switching and pathogenic autoantibody production | Q28588979 | ||
| Genetic and epigenetic fine mapping of causal autoimmune disease variants | Q28649603 | ||
| T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response | Q33578985 | ||
| Altered B cell signalling in autoimmunity | Q33924642 | ||
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. | Q34251673 | ||
| The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
| TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS | Q35168231 | ||
| B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes | Q35298764 | ||
| Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins | Q36330016 | ||
| CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions | Q36384816 | ||
| B cell exchange across the blood-brain barrier in multiple sclerosis | Q36498036 | ||
| B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. | Q36863150 | ||
| Specific peripheral B cell tolerance defects in patients with multiple sclerosis | Q36890946 | ||
| Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells | Q37365081 | ||
| B cells expressing the transcription factor T-bet drive lupus-like autoimmunity | Q37730634 | ||
| Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. | Q38720773 | ||
| Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection | Q39588420 | ||
| Determination of IgG subgroups in cerebrospinal fluid of multiple sclerosis patients and others | Q39716173 | ||
| B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production. | Q39843083 | ||
| Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal. | Q40205114 | ||
| c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses | Q40236309 | ||
| Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
| A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens | Q42290162 | ||
| CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen. | Q43089413 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 264-278 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis | |
| P478 | volume | 86 |
| Q95840980 | B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers |
| Q101351073 | The association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis impact of immunotherapies |
Search more.